In contrast to non-targeted gold nanoparticles, anti-EGFR-conjugated gold nanoparticles (30 nm) intravenous injection in 2011 was found to increase the identification of HNSCC transplanted in naked mice by CT imaging (Khademi et al., 2019). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.